T0	Interventions 48 71	routine prophylaxis vs.
T1	Interventions 72 139	on-demand treatment with sucrose-formulated recombinant factorÂ VIII
T2	Interventions 211 237	of routine prophylaxis vs.
T3	Interventions 238 283	on-demand treatment with factor VIII products
T4	Interventions 548 601	with sucrose-formulated recombinant FVIII (rFVIII-FS)
T5	Interventions 946 1031	1 to rFVIII-FS prophylaxis (25 IU kg(-1) , three times weekly) or on-demand treatment
T6	Interventions 1838 1852	with rFVIII-FS
T7	Interventions 1976 1997	established rFVIII-FS